BioSpace News Archive

Apex is a full-service design engineering, tooling, and injection molding operation focused on high performance, specialty plastics for the medical device industry.

Catabasis today reported new positive efficacy and safety results showing preservation of muscle function and sustained disease-modifying effects in boys with Duchene muscular dystrophy (DMD) in the MoveDMD trial open-label extension following 48 and 60 weeks of treatment with edasalonexent.

Obsidian today announced the presentation of preclinical data on its technology platform and applications at the Keystone Symposium on Emerging Cellular Therapies, to be held February 11-15, 2018 in Keystone, Colorado.

The study is being led by Dr. Michael Burger, principal investigator, together with co-principal investigators Professor Joachim Steinbach, Head of the Institute for Neuro-oncology at the Goethe University Hospital, and Professor Christian Senft, Department of Neurosurgery at the Goethe University Hospital in Frankfurt/Main, Germany.

Surmodics will hold its Annual Meeting of Shareholders on Wednesday, February 21, at 4:00 p.m. CT (5:00 p.m. ET), as a virtual meeting.

The RGC will use its fully-automated sample preparation and data processing, and cutting-edge cloud-based informatics to sequence the exomes in DNA samples from the ACP Repository.

ABEC announced the completion of its second ISO-7 cleanroom for single-use disposable container (DC) manufacturing.

Cytobank and the FDA are collaborating to develop machine learning-based methods for characterizing the morphology of multipotent mesenchymal stromal cells (MSCs).

IMR-687 is designed as an oral therapy for once-daily dosing to address both the underlying red and white blood cell pathologies associated with SCD.

AB569 is the Company’s inhalation drug candidate for treating antibiotic-resistant bacterial infections in the lungs of CF and COPD patients.